ACAD · ACADIA Pharmaceuticals Inc. Common Stock
View on chartInsiders & Stakes
| BAKER BROS. ADVISORS LP Director | ▲ Buy | Grant | 39,384,587 Shares held | 5/29/2026 | View profile |
| DAVIS STEPHEN CEO | ▼ Sell | Open Market | 186,555 Shares held | 8/19/2024 | View profile |
| Schneyer Mark C. Chief Financial Officer | ▼ Sell | Open Market | 67,828 Shares held | 8/6/2026 | View profile |
| Brendan Teehan Chief Commercial Officer | ▼ Sell | Open Market | 62,105 Shares held | 11/19/2024 | View profile |
| Stankovic Srdjan R. President | ▼ Sell | Open Market | 61,234 Shares held | 11/21/2022 | View profile |
| KIM AUSTIN D. EVP & General Counsel | ▼ Sell | Open Market | 46,901 Shares held | 1/8/2024 | View profile |
| Daniel B. Soland Director | ▲ Buy | Option Exercise | 44,041 Shares held | 5/29/2025 | View profile |
| Edmund Harrigan Director | ▲ Buy | Option Exercise | 43,148 Shares held | 5/29/2026 | View profile |
| Elizabeth A. Garofalo Director | ▲ Buy | Option Exercise | 33,489 Shares held | 5/29/2026 | View profile |
| Adora Ndu Director | ▲ Buy | Option Exercise | 32,908 Shares held | 5/29/2026 | View profile |
| Laura Brege Director | ▲ Buy | Option Exercise | 23,202 Shares held | 5/29/2026 | View profile |
| Thompson Elizabeth H.Z. EVP, Head of Research & Dev | ▼ Sell | Open Market | 18,994 Shares held | 7/30/2026 | View profile |
| Owen Catherine E. Director | ▼ Sell | Open Market | 14,803 Shares held | 3/25/2026 | View profile |
| Kihara James Principal Accounting Officer | ▼ Sell | Open Market | 13,088 Shares held | 6/26/2026 | View profile |
| James M. Daly Director | ▲ Buy | Option Exercise | 12,148 Shares held | 5/29/2026 | View profile |
| Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | ▼ Sell | Open Market | 11,280 Shares held | 3/25/2026 | View profile |
| Poole Jonathan | ▲ Buy | Option Exercise | 2,010 Shares held | 5/29/2026 | View profile |
Transaction History
| Schneyer Mark C. | ▲ Buy | Option Exercise | 14,292 | $255K | 8/6/2026 |
| Schneyer Mark C. | ▼ Sell | Open Market | 5,000 | $145K | 8/6/2026 |
| Schneyer Mark C. | ▼ Sell | Open Market | 9,292 | $273K | 8/6/2026 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 5,849 | $104K | 8/5/2026 |
| Schneyer Mark C. | ▼ Sell | Open Market | 5,849 | $170K | 8/5/2026 |
| Thompson Elizabeth H.Z. | ▼ Sell | Open Market | 16,508 | $431K | 7/30/2026 |
| Thompson Elizabeth H.Z. | ▼ Sell | Open Market | 50 | $1K | 7/30/2026 |
| Thompson Elizabeth H.Z. | ▲ Buy | Option Exercise | 32,272 | — | 7/29/2026 |
| Kihara James | ▼ Sell | Open Market | 11,421 | $298K | 6/26/2026 |
| Adora Ndu | ▲ Buy | Option Exercise | 8,107 | — | 5/29/2026 |
| Laura Brege | ▲ Buy | Option Exercise | 8,107 | — | 5/29/2026 |
| Edmund Harrigan | ▲ Buy | Option Exercise | 8,107 | — | 5/29/2026 |
| Poole Jonathan | ▲ Buy | Option Exercise | 2,010 | — | 5/29/2026 |
| Elizabeth A. Garofalo | ▲ Buy | Option Exercise | 8,107 | — | 5/29/2026 |
| James M. Daly | ▲ Buy | Option Exercise | 8,107 | — | 5/29/2026 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Grant | 18,622 | $0 | 5/29/2026 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Grant | 18,622 | $0 | 5/29/2026 |
| Kihara James | ▼ Sell | Open Market | 5,401 | $114K | 5/26/2026 |
| Kihara James | ▼ Sell | Open Market | 1,332 | $29K | 5/4/2026 |
| Schneyer Mark C. | ▼ Sell | Open Market | 3,506 | $76K | 5/4/2026 |
| Kihara James | ▲ Buy | Option Exercise | 2,596 | — | 5/1/2026 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 6,815 | — | 5/1/2026 |
| Schneyer Mark C. | ▼ Sell | Open Market | 2,709 | $60K | 4/7/2026 |
| Kihara James | ▼ Sell | Open Market | 1,030 | $23K | 4/7/2026 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 5,276 | — | 4/5/2026 |
| Kihara James | ▲ Buy | Option Exercise | 2,010 | — | 4/5/2026 |
| Kihara James | ▼ Sell | Open Market | 1,097 | $24K | 3/26/2026 |
| Kihara James | ▼ Sell | Open Market | 12 | $261 | 3/26/2026 |
| Schneyer Mark C. | ▼ Sell | Open Market | 3,171 | $69K | 3/26/2026 |
| Schneyer Mark C. | ▼ Sell | Open Market | 37 | $804 | 3/26/2026 |
| Thompson Elizabeth H.Z. | ▼ Sell | Open Market | 3,435 | $74K | 3/25/2026 |
| Rhodes Jennifer J | ▼ Sell | Open Market | 3,844 | $83K | 3/25/2026 |
| Kihara James | ▼ Sell | Open Market | 833 | $18K | 3/25/2026 |
| Kihara James | ▲ Buy | Option Exercise | 2,142 | — | 3/25/2026 |
| Schneyer Mark C. | ▼ Sell | Open Market | 4,177 | $90K | 3/25/2026 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 6,178 | — | 3/25/2026 |
| Owen Catherine E. | ▼ Sell | Open Market | 11,641 | $250K | 3/25/2026 |
| Thompson Elizabeth H.Z. | ▲ Buy | Option Exercise | 6,715 | — | 3/24/2026 |
| Rhodes Jennifer J | ▲ Buy | Option Exercise | 7,515 | $0 | 3/24/2026 |
| Kihara James | ▲ Buy | Option Exercise | 1,627 | — | 3/24/2026 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 8,138 | — | 3/24/2026 |
| Owen Catherine E. | ▲ Buy | Option Exercise | 23,509 | $0 | 3/24/2026 |
| Rhodes Jennifer J | ▼ Sell | Open Market | 6,950 | $162K | 2/9/2026 |
| Rhodes Jennifer J | ▲ Buy | Option Exercise | 12,944 | $0 | 2/6/2026 |
| Schneyer Mark C. | ▼ Sell | Open Market | 10,262 | $243K | 11/18/2025 |
| Kihara James | ▼ Sell | Open Market | 4,084 | $97K | 11/18/2025 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 9,913 | — | 11/17/2025 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 9,913 | — | 11/17/2025 |
| Kihara James | ▲ Buy | Option Exercise | 3,966 | — | 11/17/2025 |
| Kihara James | ▲ Buy | Option Exercise | 3,966 | — | 11/17/2025 |
| James M. Daly | ▼ Sell | Open Market | 30,000 | $671K | 11/10/2025 |
| Schneyer Mark C. | ▼ Sell | Open Market | 3,498 | $83K | 9/15/2025 |
| Schneyer Mark C. | ▲ Buy | Grant | 6,815 | $0 | 9/12/2025 |
| Elizabeth A. Garofalo | ▼ Sell | Open Market | 1,600 | $42K | 9/2/2025 |
| Schneyer Mark C. | ▼ Sell | Open Market | 22,000 | $554K | 8/18/2025 |
| Laura Brege | ▼ Sell | Open Market | 14,446 | $315K | 6/4/2025 |
| Daniel B. Soland | ▲ Buy | Option Exercise | 9,387 | — | 5/29/2025 |
| Adora Ndu | ▲ Buy | Option Exercise | 9,387 | — | 5/29/2025 |
| Edmund Harrigan | ▲ Buy | Option Exercise | 9,387 | — | 5/29/2025 |
| Elizabeth A. Garofalo | ▲ Buy | Option Exercise | 9,387 | — | 5/29/2025 |
| James M. Daly | ▲ Buy | Option Exercise | 9,387 | — | 5/29/2025 |
| Laura Brege | ▲ Buy | Option Exercise | 9,387 | — | 5/29/2025 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Grant | 16,214 | $0 | 5/29/2025 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Grant | 16,214 | $0 | 5/29/2025 |
| Kihara James | ▼ Sell | Open Market | 2,000 | $50K | 5/16/2025 |
| Kihara James | ▼ Sell | Open Market | 2,000 | $40K | 5/16/2025 |
| Schneyer Mark C. | ▼ Sell | Open Market | 2,000 | $50K | 5/16/2025 |
| Kihara James | ▼ Sell | Open Market | 1,327 | $19K | 5/2/2025 |
| Schneyer Mark C. | ▼ Sell | Open Market | 3,498 | $51K | 5/2/2025 |
| Kihara James | ▲ Buy | Option Exercise | 2,596 | — | 5/1/2025 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 6,815 | — | 5/1/2025 |
| Schneyer Mark C. | ▼ Sell | Open Market | 2,708 | $40K | 4/8/2025 |
| Kihara James | ▼ Sell | Open Market | 1,028 | $15K | 4/8/2025 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 5,275 | — | 4/5/2025 |
| Kihara James | ▲ Buy | Option Exercise | 2,010 | — | 4/5/2025 |
| Kihara James | ▼ Sell | Open Market | 1,095 | $19K | 3/26/2025 |
| Schneyer Mark C. | ▼ Sell | Open Market | 3,171 | $54K | 3/26/2025 |
| Kihara James | ▲ Buy | Option Exercise | 2,142 | — | 3/25/2025 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 6,178 | — | 3/25/2025 |
| Elizabeth A. Garofalo | ▼ Sell | Open Market | 4,919 | $90K | 3/5/2025 |
| Kihara James | ▼ Sell | Open Market | 475 | $9K | 2/24/2025 |
| Schneyer Mark C. | ▼ Sell | Open Market | 773 | $15K | 2/24/2025 |
| Kihara James | ▲ Buy | Option Exercise | 840 | — | 2/23/2025 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 1,353 | — | 2/23/2025 |
| Brendan Teehan | ▼ Sell | Open Market | 10,329 | $174K | 11/19/2024 |
| Kihara James | ▼ Sell | Open Market | 4,073 | $68K | 11/19/2024 |
| Schneyer Mark C. | ▼ Sell | Open Market | 10,259 | $172K | 11/19/2024 |
| Brendan Teehan | ▲ Buy | Option Exercise | 9,913 | — | 11/17/2024 |
| Kihara James | ▲ Buy | Option Exercise | 3,965 | — | 11/17/2024 |
| Kihara James | ▲ Buy | Option Exercise | 3,965 | — | 11/17/2024 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 9,913 | — | 11/17/2024 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 9,913 | — | 11/17/2024 |
| Brendan Teehan | ▲ Buy | Option Exercise | 9,913 | — | 11/17/2024 |
| Adora Ndu | ▲ Buy | Option Exercise | 4,381 | — | 10/12/2024 |
| Schneyer Mark C. | ▼ Sell | Open Market | 9,733 | $149K | 8/19/2024 |
| Brendan Teehan | ▼ Sell | Open Market | 9,534 | $146K | 8/19/2024 |
| DAVIS STEPHEN | ▼ Sell | Open Market | 31,747 | $485K | 8/19/2024 |
| Brendan Teehan | ▲ Buy | Grant | 5,024 | $0 | 8/16/2024 |
| Brendan Teehan | ▲ Buy | Grant | 13,629 | $0 | 8/16/2024 |
| DAVIS STEPHEN | ▲ Buy | Grant | 17,333 | $0 | 8/16/2024 |
| DAVIS STEPHEN | ▲ Buy | Grant | 44,782 | $0 | 8/16/2024 |
| Schneyer Mark C. | ▲ Buy | Grant | 13,629 | $0 | 8/16/2024 |
| Schneyer Mark C. | ▲ Buy | Grant | 5,275 | $0 | 8/16/2024 |
| Schneyer Mark C. | ▼ Sell | Open Market | 975 | $14K | 6/10/2024 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 1,893 | — | 6/8/2024 |
| Edmund Harrigan | ▲ Buy | Option Exercise | 6,652 | — | 5/29/2024 |
| Daniel B. Soland | ▲ Buy | Option Exercise | 6,652 | — | 5/29/2024 |
| Laura Brege | ▲ Buy | Option Exercise | 6,652 | — | 5/29/2024 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Grant | 18,774 | $0 | 5/29/2024 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Grant | 18,774 | $0 | 5/29/2024 |
| Adora Ndu | ▲ Buy | Option Exercise | 6,652 | — | 5/29/2024 |
| Elizabeth A. Garofalo | ▲ Buy | Option Exercise | 6,652 | — | 5/29/2024 |
| James M. Daly | ▲ Buy | Option Exercise | 6,652 | — | 5/29/2024 |
| Schneyer Mark C. | ▼ Sell | Open Market | 3,503 | $59K | 5/2/2024 |
| Brendan Teehan | ▼ Sell | Open Market | 3,477 | $59K | 5/2/2024 |
| Kihara James | ▼ Sell | Open Market | 1,326 | $22K | 5/2/2024 |
| DAVIS STEPHEN | ▼ Sell | Open Market | 11,427 | $194K | 5/2/2024 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 6,814 | — | 5/1/2024 |
| Brendan Teehan | ▲ Buy | Option Exercise | 6,814 | — | 5/1/2024 |
| Kihara James | ▲ Buy | Option Exercise | 2,596 | — | 5/1/2024 |
| DAVIS STEPHEN | ▲ Buy | Option Exercise | 22,391 | — | 5/1/2024 |
| DAVIS STEPHEN | ▼ Sell | Open Market | 8,858 | $158K | 4/8/2024 |
| DAVIS STEPHEN | ▼ Sell | Open Market | 17,716 | $317K | 4/8/2024 |
| Brendan Teehan | ▼ Sell | Open Market | 2,568 | $46K | 4/8/2024 |
| Kihara James | ▼ Sell | Open Market | 1,028 | $18K | 4/8/2024 |
| Kihara James | ▼ Sell | Open Market | 762 | $14K | 4/8/2024 |
| Schneyer Mark C. | ▼ Sell | Open Market | 2,716 | $49K | 4/8/2024 |
| Kihara James | ▲ Buy | Option Exercise | 1,489 | — | 4/7/2024 |
| DAVIS STEPHEN | ▲ Buy | Option Exercise | 17,333 | — | 4/5/2024 |
| DAVIS STEPHEN | ▲ Buy | Option Exercise | 34,666 | — | 4/5/2024 |
| Brendan Teehan | ▲ Buy | Option Exercise | 5,024 | — | 4/5/2024 |
| Kihara James | ▲ Buy | Option Exercise | 2,010 | — | 4/5/2024 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 5,275 | — | 4/5/2024 |
| DAVIS STEPHEN | ▼ Sell | Open Market | 17,714 | $317K | 3/27/2024 |
| Brendan Teehan | ▼ Sell | Open Market | 5,140 | $92K | 3/27/2024 |
| Schneyer Mark C. | ▼ Sell | Open Market | 5,434 | $97K | 3/27/2024 |
| Schneyer Mark C. | ▲ Buy | Grant | 10,550 | $0 | 3/25/2024 |
| DAVIS STEPHEN | ▲ Buy | Grant | 34,666 | $0 | 3/25/2024 |
| Brendan Teehan | ▲ Buy | Grant | 10,048 | $0 | 3/25/2024 |
| Schneyer Mark C. | ▼ Sell | Open Market | 772 | $19K | 2/26/2024 |
| Brendan Teehan | ▼ Sell | Open Market | 624 | $15K | 2/26/2024 |
| Kihara James | ▼ Sell | Open Market | 474 | $12K | 2/26/2024 |
| DAVIS STEPHEN | ▼ Sell | Open Market | 5,577 | $138K | 2/26/2024 |
| Brendan Teehan | ▲ Buy | Option Exercise | 1,107 | — | 2/23/2024 |
| Kihara James | ▲ Buy | Option Exercise | 840 | — | 2/23/2024 |
| DAVIS STEPHEN | ▲ Buy | Option Exercise | 10,946 | — | 2/23/2024 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 1,353 | — | 2/23/2024 |
| DAVIS STEPHEN | ▼ Sell | Open Market | 3,732 | $112K | 1/8/2024 |
| Brendan Teehan | ▼ Sell | Open Market | 731 | $22K | 1/8/2024 |
| KIM AUSTIN D. | ▼ Sell | Open Market | 590 | $18K | 1/8/2024 |
| DAVIS STEPHEN | ▲ Buy | Option Exercise | 9,528 | — | 1/6/2024 |
| Brendan Teehan | ▲ Buy | Option Exercise | 1,287 | — | 1/6/2024 |
| KIM AUSTIN D. | ▲ Buy | Option Exercise | 1,634 | — | 1/6/2024 |
| Kihara James | ▼ Sell | Open Market | 2,000 | $57K | 12/15/2023 |
| Elizabeth A. Garofalo | ▼ Sell | Gift | 2,918 | $0 | 11/24/2023 |
| Brendan Teehan | ▼ Sell | Open Market | 4,960 | $112K | 11/20/2023 |
| Schneyer Mark C. | ▼ Sell | Open Market | 5,108 | $116K | 11/20/2023 |
| Kihara James | ▼ Sell | Open Market | 1,985 | $45K | 11/20/2023 |
| Brendan Teehan | ▲ Buy | Option Exercise | 4,956 | — | 11/17/2023 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 4,956 | — | 11/17/2023 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 4,956 | — | 11/17/2023 |
| Kihara James | ▲ Buy | Option Exercise | 1,982 | — | 11/17/2023 |
| Brendan Teehan | ▲ Buy | Option Exercise | 4,956 | — | 11/17/2023 |
| Kihara James | ▲ Buy | Option Exercise | 1,982 | — | 11/17/2023 |
| Adora Ndu | ▲ Buy | Option Exercise | 4,381 | — | 10/12/2023 |
| KIM AUSTIN D. | ▼ Sell | Open Market | 16,369 | $359K | 10/6/2023 |
| DAVIS STEPHEN | ▼ Sell | Open Market | 51,563 | $1.1M | 10/6/2023 |
| KIM AUSTIN D. | ▲ Buy | Option Exercise | 36,174 | — | 10/5/2023 |
| DAVIS STEPHEN | ▲ Buy | Option Exercise | 103,999 | — | 10/5/2023 |
| Kihara James | ▼ Sell | Open Market | 2,000 | $52K | 9/15/2023 |
| Schneyer Mark C. | ▼ Sell | Open Market | 10,000 | $290K | 8/21/2023 |
| DAVIS STEPHEN | ▲ Buy | Option Exercise | 100,000 | $2.1M | 7/14/2023 |
| DAVIS STEPHEN | ▼ Sell | Open Market | 100,000 | $3.0M | 7/14/2023 |
| DAVIS STEPHEN | ▼ Sell | Open Market | 55,104 | $1.4M | 7/12/2023 |
| DAVIS STEPHEN | ▼ Sell | Open Market | 16,498 | $412K | 7/11/2023 |
| Kihara James | ▼ Sell | Open Market | 2,000 | $48K | 6/15/2023 |
| Laura Brege | ▼ Sell | Open Market | 4,500 | $112K | 6/12/2023 |
| Schneyer Mark C. | ▲ Buy | Option Exercise | 1,893 | $0 | 6/8/2023 |
| Schneyer Mark C. | ▼ Sell | Open Market | 974 | $24K | 6/8/2023 |
| Daniel B. Soland | ▲ Buy | Option Exercise | 8,552 | — | 6/1/2023 |
| Laura Brege | ▲ Buy | Option Exercise | 8,552 | — | 6/1/2023 |
| Edmund Harrigan | ▲ Buy | Option Exercise | 8,552 | — | 6/1/2023 |
| James M. Daly | ▲ Buy | Option Exercise | 8,552 | — | 6/1/2023 |
| Elizabeth A. Garofalo | ▲ Buy | Option Exercise | 8,552 | — | 6/1/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Grant | 13,304 | $0 | 6/1/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Grant | 13,304 | $0 | 6/1/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Open Market | 20,304 | $513K | 5/24/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Open Market | 218,171 | $5.5M | 5/24/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Open Market | 2,688 | $69K | 5/24/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Open Market | 28,878 | $737K | 5/24/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Open Market | 24,113 | $618K | 5/24/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Open Market | 259,109 | $6.6M | 5/24/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Option Exercise | 12,500 | $213K | 5/23/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Option Exercise | 12,500 | $213K | 5/23/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Open Market | 10,858 | $275K | 5/23/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Open Market | 116,672 | $3.0M | 5/23/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Open Market | 6,941 | $177K | 5/23/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Open Market | 74,582 | $1.9M | 5/23/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Open Market | 3,781 | $94K | 5/22/2023 |
| BAKER BROS. ADVISORS LP | ▲ Buy | Open Market | 40,632 | $1.0M | 5/22/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
RBC Lowers ACAD Target to $36 Amid Patent and Phase 2 Updates
RBC Capital maintained an Outperform rating on Acadia Pharmaceuticals but lowered its price target to $36. This move comes as the company reports progress on patents and Phase 2 trials. Recent articles also suggest the stock may be trading below its estimated fair value, highlighting a contrast between current market pricing and fundamental developments.
RBC Lowers ACAD Target to $36 Amid Patent and Phase 2 Updates. RBC Capital maintained an Outperform rating on Acadia Pharmaceuticals but lowered its price target to $36. This move comes as the company reports progress on patents and Phase 2 trials. Recent articles also suggest the stock may be trading below its estimated fair value, highlighting a contrast between current market pricing and fundamental developments.